The ins and outs of nanoparticle technology in neurodegenerative diseases and cancer

CM Wilson, A Magnaudeix, T Naves… - Current Drug …, 2015 - ingentaconnect.com
As we enter the twenty-first century, several therapies based on using nanoparticles (NPs)
ranging in size 1–1000 nm have been successfully brought to the clinic to treat cancer, pain …

[HTML][HTML] Biomedical applications of superparamagnetic iron oxide nanoparticles (SPIONS) as a theranostic agent

N Jaswal, P Justa, H Kumar, B Pani… - Iron Ores and Iron …, 2023 - intechopen.com
Nowadays, nanoparticles are used in a variety of biological applications where they
enhance treatments and laboratory tests. Due to their distinctive properties and minor …

A review of superparamagnetic nanoparticles applications and regulatory aspects in medicine and environmental areas

DW Losito, NIN Souza, TS Martins, TN Britos… - Journal of Materials …, 2024 - Springer
This review paper highlights the current toxicological aspects of magnetic nanomaterials in
the field of medicine and the environment, conducted through a comprehensive literature …

[PDF][PDF] Silver nano particles ameliorate learning and spatial memory of male Wistar rats by prevention of amyloid fibril-induced neurotoxicity

H Ramshini, AS Moghaddasi, LS Aldaghi… - Arch. Ital …, 2017 - researchgate.net
Alzheimer's disease (AD) is a chronic degenerative disease characterized by the presence
of amyloid plaques and neurofibrillary tangles (NFTs), which results into memory and …

Nanostructure-Based Molecules as Diagnostic and Theranostic Tools in Alzheimer's Disease

T Suthar, K Jain - Natural Product-based Synthetic Drug Molecules in …, 2023 - Springer
Abstract Alzheimer's disease (AD), a neurodegenerative disorder characterized by
progressive, continuous, and irreversible degeneration of structure and function of neurons …

Claulansine F–donepezil hybrids as anti-Alzheimer's disease agents with cholinergic, free-radical scavenging, and neuroprotective activities

Y Zang, K Liu, W Wang, C Li, J Ma, J Yang, X Chen… - Molecules, 2021 - mdpi.com
The multifactorial nature of Alzheimer's disease (AD) calls for the development of multitarget
agents addressing key pathogenic processes. A total of 26 Claulansine F–donepezil hybrids …

Multiple effects of polydopamine nanoparticles on Cu2+-mediated Alzheimer's β-amyloid aggregation

X Chen, W Gao, Y Sun, X Dong - Chinese Journal of Chemical Engineering, 2023 - Elsevier
Deposition of β-amyloid protein (Aβ) is the main hallmark of Alzheimer's disease (AD), and it
has been well recognized that Cu 2+-mediated Aβ aggregation plays a crucial role in AD …

Lipocalin‐Type Prostaglandin d Synthase Conjugates as Magnetic Resonance Imaging Contrast Agents for Detecting Amyloid β‐Rich Regions in the Brain of Live …

B Sharma, J Grandjean, M Phillips… - Advanced …, 2021 - Wiley Online Library
With a significant proportion of the global population growing older (> 60 years), the low
success rates of current diagnoses for early neurodegeneration signs are disappointing …

Newborn Neurons Are Damaged In Vitro by a Low Concentration of Silver Nanoparticles Through the Inflammatory Oxidative Stress Pathway

X Guo, G Zhang, L Chen, AA Khan, B Gu… - DNA and Cell Biology, 2017 - liebertpub.com
With increasing applications of nanomaterials, including silver nanoparticles (AgNPs),
unknown potential risks are present against humans and the environment, especially to the …

[图书][B] Metal Nanocomposites in Nanotherapeutics for Oxidative Stress-Induced Metabolic Disorders

A Behera - 2023 - books.google.com
This book highlights the role and mechanism of different metal nanocomposites toward
oxidative stress-induced metabolic disorders including metabolic pathways affected by …